Logo image of ECCX

EAGLE POINT CREDIT CO - ECC 6.6875 04/30/28 (ECCX) Stock Fundamental Analysis

NYSE:ECCX - New York Stock Exchange, Inc. - US2698095054 - Currency: USD

24.95  0 (0%)

Fundamental Rating

3

Overall ECCX gets a fundamental rating of 3 out of 10. We evaluated ECCX against 0 industry peers in the Unkown industry. Both the profitability and financial health of ECCX have multiple concerns. ECCX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ECCX was profitable.
ECCX had a negative operating cash flow in the past year.
ECCX had positive earnings in 4 of the past 5 years.
In the past 5 years ECCX reported 4 times negative operating cash flow.
ECCX Yearly Net Income VS EBIT VS OCF VS FCFECCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M -400M

1.2 Ratios

Industry RankSector Rank
ROA -3.6%
ROE -5.15%
ROIC 6.48%
ROA(3y)1.32%
ROA(5y)6.59%
ROE(3y)1.24%
ROE(5y)9.12%
ROIC(3y)6.93%
ROIC(5y)6.24%
ECCX Yearly ROA, ROE, ROICECCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

ECCX's Profit Margin has declined in the last couple of years.
ECCX's Operating Margin has improved in the last couple of years.
In the last couple of years the Gross Margin of ECCX has grown nicely.
Industry RankSector Rank
OM 60.46%
PM (TTM) N/A
GM 63.17%
OM growth 3Y5.72%
OM growth 5Y2.96%
PM growth 3Y-33.04%
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.17%
ECCX Yearly Profit, Operating, Gross MarginsECCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, ECCX has more shares outstanding
Compared to 5 years ago, ECCX has more shares outstanding
Compared to 1 year ago, ECCX has a worse debt to assets ratio.
ECCX Yearly Shares OutstandingECCX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ECCX Yearly Total Debt VS Total AssetsECCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

ECCX has an Altman-Z score of 4.12. This indicates that ECCX is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.38 indicates that ECCX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 4.12
ROIC/WACCN/A
WACCN/A
ECCX Yearly LT Debt VS Equity VS FCFECCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 2.22 indicates that ECCX has no problem at all paying its short term obligations.
ECCX has a Quick Ratio of 2.22. This indicates that ECCX is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 2.22
ECCX Yearly Current Assets VS Current LiabilitesECCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

ECCX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.73%.
Measured over the past years, ECCX shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.24% on average per year.
The Revenue has grown by 29.26% in the past year. This is a very strong growth!
The Revenue has been growing by 22.03% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-22.73%
EPS 3Y-5.35%
EPS 5Y-2.24%
EPS Q2Q%-35.29%
Revenue 1Y (TTM)29.26%
Revenue growth 3Y26.64%
Revenue growth 5Y22.03%
Sales Q2Q%14.54%

3.2 Future

The Earnings Per Share is expected to decrease by -9.64% on average over the next years.
The Revenue is expected to grow by 16.22% on average over the next years. This is quite good.
EPS Next Y-12.57%
EPS Next 2Y-9.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.04%
Revenue Next 2Y16.22%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ECCX Yearly Revenue VS EstimatesECCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ECCX Yearly EPS VS EstimatesECCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ECCX is valuated rather expensively with a Price/Earnings ratio of 24.46.
The average S&P500 Price/Earnings ratio is at 26.93. ECCX is around the same levels.
The Price/Forward Earnings ratio is 26.12, which means the current valuation is very expensive for ECCX.
The average S&P500 Price/Forward Earnings ratio is at 35.31. ECCX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 24.46
Fwd PE 26.12
ECCX Price Earnings VS Forward Price EarningsECCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ECCX Per share dataECCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

ECCX's earnings are expected to decrease with -9.64% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.64%
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.38%, ECCX is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.39, ECCX pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.38%

5.2 History

ECCX has been paying a dividend for over 5 years, so it has already some track record.
ECCX has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
ECCX Yearly Dividends per shareECCX Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

The earnings of ECCX are negative and hence is the payout ratio. ECCX will probably not be able to sustain this dividend level.
DP-326.46%
EPS Next 2Y-9.64%
EPS Next 3YN/A
ECCX Yearly Income VS Free CF VS DividendECCX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M -400M

More info and screens

EAGLE POINT CREDIT CO - ECC 6.6875 04/30/28

NYSE:ECCX (8/14/2025, 8:14:16 PM)

24.95

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners8.61%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap3.00B
Analysts77.78
Price Target30.11 (20.68%)
Short Float %0%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield 8.38%
Yearly Dividend1.74
Dividend Growth(5Y)N/A
DP-326.46%
Div Incr Years2
Div Non Decr Years2
Ex-Date06-16 2025-06-16 (0.418)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.14%
Min EPS beat(2)-13.9%
Max EPS beat(2)3.62%
EPS beat(4)2
Avg EPS beat(4)-5.6%
Min EPS beat(4)-13.9%
Max EPS beat(4)3.62%
EPS beat(8)3
Avg EPS beat(8)-6.78%
EPS beat(12)4
Avg EPS beat(12)-7.9%
EPS beat(16)6
Avg EPS beat(16)-5.88%
Revenue beat(2)0
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-1.41%
Max Revenue beat(2)-0.85%
Revenue beat(4)1
Avg Revenue beat(4)-1.27%
Min Revenue beat(4)-6.65%
Max Revenue beat(4)3.83%
Revenue beat(8)3
Avg Revenue beat(8)-1.05%
Revenue beat(12)6
Avg Revenue beat(12)-1.21%
Revenue beat(16)9
Avg Revenue beat(16)0.08%
PT rev (1m)11.36%
PT rev (3m)2.15%
EPS NQ rev (1m)-0.81%
EPS NQ rev (3m)-4.65%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.99%
Revenue NQ rev (1m)-0.55%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)-0.63%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE 24.46
Fwd PE 26.12
P/S 15.7
P/FCF N/A
P/OCF N/A
P/B 2.95
P/tB 2.95
EV/EBITDA N/A
EPS(TTM)1.02
EY4.09%
EPS(NY)0.96
Fwd EY3.83%
FCF(TTM)-3.37
FCFYN/A
OCF(TTM)-3.37
OCFYN/A
SpS1.59
BVpS8.47
TBVpS8.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.6%
ROE -5.15%
ROCE 8.2%
ROIC 6.48%
ROICexc 6.48%
ROICexgc 6.48%
OM 60.46%
PM (TTM) N/A
GM 63.17%
FCFM N/A
ROA(3y)1.32%
ROA(5y)6.59%
ROE(3y)1.24%
ROE(5y)9.12%
ROIC(3y)6.93%
ROIC(5y)6.24%
ROICexc(3y)7.33%
ROICexc(5y)6.51%
ROICexgc(3y)7.34%
ROICexgc(5y)6.51%
ROCE(3y)8.78%
ROCE(5y)7.89%
ROICexcg growth 3Y7.57%
ROICexcg growth 5Y-0.43%
ROICexc growth 3Y7.47%
ROICexc growth 5Y-0.49%
OM growth 3Y5.72%
OM growth 5Y2.96%
PM growth 3Y-33.04%
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.17%
F-Score0
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 5.48
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.22
Quick Ratio 2.22
Altman-Z 4.12
F-Score0
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.73%
EPS 3Y-5.35%
EPS 5Y-2.24%
EPS Q2Q%-35.29%
EPS Next Y-12.57%
EPS Next 2Y-9.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)29.26%
Revenue growth 3Y26.64%
Revenue growth 5Y22.03%
Sales Q2Q%14.54%
Revenue Next Year22.04%
Revenue Next 2Y16.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.8%
EBIT growth 3Y33.88%
EBIT growth 5Y25.64%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-531.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-531.18%
OCF growth 3YN/A
OCF growth 5YN/A